Gene Therapy: IT Meets Medicine, But Who Is In Charge?
A biotechnology CEO would like to see patients have more power in determining advanced treatmentsJay Richards talked recently with Matt Scholz, Founder & CEO of Oisín Biotechnologies, about the challenges and promises of the information theory of biotech, especially as related to medicine: The panel in which Scholz participated at COSM 2019 focused on how artificial intelligence can make a difference in medicine: From the interview: Jay Richards: So how would you distill this panel? It was you and Babak Parviz, formerly of Google Glass and now from Amazon (and formerly Google Glass) and Lindy Fishburne, who’s on the funding side of information technology and biology. Matt Scholz: The panel was put together ranging from the computational side of it to the actual therapeutic side and finance. So I think that made it a Read More ›
